![Rab Prinjha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rab Prinjha
Director/Board Member at
Padlock Therapeutics, Inc.
Profile
Rab Prinjha is currently a Director at Padlock Therapeutics, Inc. He previously worked as the Head of Epigenetics Discovery Performance Unit at GSK Plc.
He obtained a doctorate degree from University College London.
Rab Prinjha active positions
| Companies | Position | Start |
|---|---|---|
Padlock Therapeutics, Inc.
 Padlock Therapeutics, Inc. BiotechnologyHealth Technology Develops medicines targeting protein-arginine deiminases | Director/Board Member | - |
Former positions of Rab Prinjha
| Companies | Position | End |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
Training of Rab Prinjha
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Develops medicines targeting protein-arginine deiminases | Health Technology |
- Stock Market
- Insiders
- Rab Prinjha
